Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason J Lohmueller

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal for Immunotherapy of Cancer|May 8, 2026
PSCA CAR Vδ1 T cells: a safer off-the-shelf CAR T therapy for pancreatic cancer?Joseph A Fraietta, Jason J Lohmueller
Nucleic Acids Research|February 11, 2012
A tunable zinc finger-based framework for Boolean logic computation in mammalian cellsJason J Lohmueller, Thomas Z Armel, Pamela A Silver
Nature Reviews. Molecular Cell Biology|January 18, 2014
Synthetic biology in mammalian cells: next generation research tools and therapeuticsFlorian Lienert, Jason J Lohmueller, Abhishek Garg, et al.
Journal of the American Chemical Society|April 30, 2013
Protein scaffold-activated protein trans-splicing in mammalian cellsDaniel F Selgrade, Jason J Lohmueller, Florian Lienert, et al.
Oncoimmunology|January 4, 2018
mSA2 affinity-enhanced biotin-binding CAR T cells for universal tumor targetingJason J Lohmueller, James D Ham, Michael Kvorjak, et al.
Nucleic Acids Research|May 15, 2012
Engineering synthetic TAL effectors with orthogonal target sitesAbhishek Garg, Jason J Lohmueller, Pamela A Silver, et al.
Oncotarget|December 30, 2017
Abnormally glycosylated MUC1 establishes a positive feedback circuit of inflammatory cytokines, mediated by NF-κB p65 and EzH2, in colitis-associated cancerSandra Cascio, Jacque L Faylo, Joshua C Sciurba, et al.
Scientific Reports|August 23, 2016
Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potentialJason J Lohmueller, Shuji Sato, Lana Popova, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal for Immunotherapy of Cancer|May 8, 2026
PSCA CAR Vδ1 T cells: a safer off-the-shelf CAR T therapy for pancreatic cancer?Joseph A Fraietta, Jason J Lohmueller
Nucleic Acids Research|February 11, 2012
A tunable zinc finger-based framework for Boolean logic computation in mammalian cellsJason J Lohmueller, Thomas Z Armel, Pamela A Silver
Nature Reviews. Molecular Cell Biology|January 18, 2014
Synthetic biology in mammalian cells: next generation research tools and therapeuticsFlorian Lienert, Jason J Lohmueller, Abhishek Garg, et al.
Journal of the American Chemical Society|April 30, 2013
Protein scaffold-activated protein trans-splicing in mammalian cellsDaniel F Selgrade, Jason J Lohmueller, Florian Lienert, et al.
Oncoimmunology|January 4, 2018
mSA2 affinity-enhanced biotin-binding CAR T cells for universal tumor targetingJason J Lohmueller, James D Ham, Michael Kvorjak, et al.
Nucleic Acids Research|May 15, 2012
Engineering synthetic TAL effectors with orthogonal target sitesAbhishek Garg, Jason J Lohmueller, Pamela A Silver, et al.
Oncotarget|December 30, 2017
Abnormally glycosylated MUC1 establishes a positive feedback circuit of inflammatory cytokines, mediated by NF-κB p65 and EzH2, in colitis-associated cancerSandra Cascio, Jacque L Faylo, Joshua C Sciurba, et al.
Scientific Reports|August 23, 2016
Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potentialJason J Lohmueller, Shuji Sato, Lana Popova, et al.
Pageof 1